|

CD70 CAR-T cells Clinical Trials

4 actively recruiting trials

Also known as: CD70 CAR-T cells injection

Pipeline

Early 1: 1Phase 1: 3

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd2
  • Zhejiang University1
  • Weijia Fang, MD1

Indications

  • Cancer4
  • Cervix Cancer3
  • Ovarian Cancer3
  • Renal Cell Carcinoma2
  • Advanced Cancer2

Other4 trials

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
Phase 1
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.